Matthew Stanton
CIK 1814198 · CHIEF SCIENTIFIC OFFICER · last filed 2024-10-17
Matthew Stanton is a CHIEF SCIENTIFIC OFFICER who has filed 32 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for GBIO, was dated Oct 17, 2024. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
32
-$2.90M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Generation Bio Co. (GBIO) Delisted | CHIEF SCIENTIFIC OFFICER | 247,319 | $5.34 | $1.32M | -$2.90M | 32 | 2024-10-17 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-17 | Generation Bio Co. (GBIO) Delisted | Mixed | +1,182 | -$1.2K | EDGAR |
| 2024-07-17 | Generation Bio Co. (GBIO) Delisted | Mixed | +1,182 | -$1.4K | EDGAR |
| 2024-04-17 | Generation Bio Co. (GBIO) Delisted | Mixed | +1,182 | -$1.8K | EDGAR |
| 2024-01-17 | Generation Bio Co. (GBIO) Delisted | Mixed | +9,234 | -$9.4K | EDGAR |
| 2024-01-03 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-05 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-17 | Generation Bio Co. (GBIO) Delisted | Mixed | +5,254 | -$7.1K | EDGAR |
| 2023-07-18 | Generation Bio Co. (GBIO) Delisted | Mixed | +5,254 | -$11.1K | EDGAR |
| 2023-04-18 | Generation Bio Co. (GBIO) Delisted | Mixed | +5,254 | -$9.8K | EDGAR |
| 2023-01-24 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |